Xilio Therapeutics XLO
NASDAQ XLO
$7.57 -0.46 (-5.73%)
At close: Oct 23, 2026 · 4:00 PM EDT

Xilio Therapeutics (XLO) Cash & Current Investments (2020 - 2026)

Updated

Xilio Therapeutics' Cash & Current Investments was $136.04 million in Q2 2026, up 11.9% from $121.55 million a year earlier but down 9.5% from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Xilio Therapeutics came in at $137.53 million, up 148.7% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $55.29 million in FY2024 (+23.7%), $44.7 million in FY2023 (-62.9%), $120.39 million in FY2022 (-39.2%) and $198.05 million in FY2021 (+929.5%).
  • Quarterly Cash & Current Investments has moved between $33.98 million (Q1 2024) and $198.05 million (Q4 2021) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for eight straight quarters, with growth averaging 68.7% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 929.5%); the worst was Q1 2024 (a decline of 63.6%).
  • Per Business Quant data, XLO's Cash & Current Investments in the three quarters before Q2 2026 was $150.33 million (Q1 2026), $137.53 million (Q4 2025) and $103.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Xilio Therapeutics 146.89 Mn -380.77 Mn - 136.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136.04 Mn
Mar 31, 2026 150.33 Mn
Dec 31, 2025 137.53 Mn
Sep 30, 2025 103.76 Mn
Jun 30, 2025 121.55 Mn
Mar 31, 2025 89.07 Mn
Dec 31, 2024 55.29 Mn
Sep 30, 2024 61.26 Mn
Jun 30, 2024 74.95 Mn
Mar 31, 2024 33.98 Mn
Dec 31, 2023 44.70 Mn
Sep 30, 2023 59.77 Mn
Jun 30, 2023 75.38 Mn
Mar 31, 2023 93.27 Mn
Dec 31, 2022 120.39 Mn
Sep 30, 2022 139.14 Mn
Jun 30, 2022 159.41 Mn
Mar 31, 2022 176.96 Mn
Dec 31, 2021 198.05 Mn
Sep 30, 2021 99.77 Mn
API Access

Xilio Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XLO&period=max&api_key=YOUR_API_KEY